PETER RICHARDSON to Infliximab
This is a "connection" page, showing publications PETER RICHARDSON has written about Infliximab.
Connection Strength
0.063
-
Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists. Inflamm Bowel Dis. 2017 02; 23(2):254-260.
Score: 0.036
-
Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013 Oct; 11(10):1281-7.
Score: 0.028